| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014301 |
| Receipt No. | R000016655 |
| Scientific Title | micro-marsupialization for the treatment of mucous-retention cysts |
| Date of disclosure of the study information | 2014/06/20 |
| Last modified on | 2021/01/08 (Ver. 5) |
| Basic information | ||
| Public title | micro-marsupialization for the treatment of mucous-retention cysts | |
| Acronym | micro-marsupialization for the treatment of mucous-retention cysts | |
| Scientific Title | micro-marsupialization for the treatment of mucous-retention cysts | |
| Scientific Title:Acronym | micro-marsupialization for the treatment of mucous-retention cysts | |
| Region |
|
|
| Condition | ||
| Condition | mucous-retention cysts | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Attempts to micro-marsupialization with respect to mucous-retention cysts, consider outcomes, adaptation cases. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change before and after treatment of mucous-retention cysts. |
| Key secondary outcomes | Improvement of the tumor
Improvement of subjective symptoms Adverse event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Suturing in the cyst wall on to penetrate the cyst cavity silk.
Get the effect by fenestration fenestration hole formed by radical healing of the cyst wall in contact with the silk thread. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients who have been diagnosed mucus cyst(mucus aneurysm, ranine).
2.Patients with the intent and ability of the hospital 3.After receiving a sufficient explanation Upon participation in this study, on a full understanding, patients who obtained the document voluntary consent of (guardian if a minor) patient himself. |
|||
| Key exclusion criteria | 1.Patients suffering from severe diabetes.
2. Patients suffering from infectiousdiseases having a difficult to control activity. 3. Patients have a liver dysfunction. 4. Patients suspected of pregnancy or are pregnant. 5. Patients principal investigator was deemed inappropriate as subjects. |
|||
| Target sample size | 30 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki University Hospital | ||||||
| Division name | department of Regerative Oral Surgery | ||||||
| Zip code | |||||||
| Address | 1-7-1 Sakamoto,Nagasaki | ||||||
| TEL | 095-819-7704 | ||||||
| khiroe@nagasaki-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki University Hospital | ||||||
| Division name | department of Regerative Oral Surgery | ||||||
| Zip code | |||||||
| Address | 1-7-1 Sakamoto,Nagasaki | ||||||
| TEL | 095-819-7704 | ||||||
| Homepage URL | |||||||
| khiroe@nagasaki-u.ac.jp | |||||||
| Sponsor | |
| Institute | Nagasaki University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016655 |